SCHEMBL5774979

SCHEMBL5774979

CCCCCCCCCCCCCc1nc(C(C(=O)Nc2c(OC)cc(OC)cc2OC)c2ccccc2)no1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7513941 1.00
SCHEMBL5771584 0.85
SCHEMBL7497777 0.84
SCHEMBL5771505 0.83
SCHEMBL7498780 0.83
SCHEMBL7550722 0.77
SCHEMBL6936809 0.77
SCHEMBL6937086 0.77
SCHEMBL6940162 0.77
SCHEMBL7503301 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203767-B1 Heterocyclic-substituted alkylamide acat inhibitors WARNER LAMBERT CO (US) 2006-01-04 EP claimed
EP-1203767-A1 Heterocyclic-substituted alkylamide acat inhibitors WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-0684945-A1 HETEROCYCLIC-SUBSTITUTED ALKYL AMIDE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1995-12-06 EP claimed
WO-1994019330-A1 HETEROCYCLIC-SUBSTITUTED ALKYL AMIDE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1994-09-01 WO claimed